The US Food and Drug Administration (FDA) has approved LivaNova’s vagus nerve stimulation (VNS) therapy (VNS Therapy) system for use as an adjunctive treatment in reducing the frequency of seizures in patients aged 4 years and older with partial-onset seizures refractory to antiepileptic medications, the company has announced.
This is wonderful news now the vagus nerve stimulation (VNS) therapy (VNS Therapy) system can be used as an adjunctive treatment in reducing the frequency of seizure (s)
for children.
As a adult who has the vagus nerve stimulation (VNS) therapy (VNS Therapy ) in my body
and how in my case it helps when I sometimes have a aa ( aura ) before my seizure I can use my magnet to help stop the seizure or reduce it.
This is good news please keep us informed.